These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16803860)

  • 1. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice.
    Li X; Need AB; Baez M; Witkin JM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):254-9. PubMed ID: 16803860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
    Belozertseva IV; Kos T; Popik P; Danysz W; Bespalov AY
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):172-9. PubMed ID: 16630709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
    Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
    Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
    Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
    Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice.
    Pomierny-Chamioło L; Poleszak E; Pilc A; Nowak G
    Pharmacol Rep; 2010; 62(6):1186-90. PubMed ID: 21273676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
    Pałucha-Poniewiera A; Szewczyk B; Pilc A
    Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
    Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
    Nowak G; Pomierny-Chamioło L; Siwek A; Niedzielska E; Pomierny B; Pałucha-Poniewiera A; Pilc A
    Neuropharmacology; 2014 Sep; 84():46-51. PubMed ID: 24796254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
    Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
    Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats.
    Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A
    Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5.
    Fuxe K; Borroto-Escuela DO
    Expert Opin Investig Drugs; 2015; 24(9):1247-60. PubMed ID: 26219727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity.
    Kato T; Takata M; Kitaichi M; Kassai M; Inoue M; Ishikawa C; Hirose W; Yoshida K; Shimizu I
    Eur J Pharmacol; 2015 Jun; 757():11-20. PubMed ID: 25823809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents.
    Page ME; Szeliga P; Gasparini F; Cryan JF
    Psychopharmacology (Berl); 2005 Apr; 179(1):240-6. PubMed ID: 15717212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).
    Anderson JJ; Bradbury MJ; Giracello DR; Chapman DF; Holtz G; Roppe J; King C; Cosford ND; Varney MA
    Eur J Pharmacol; 2003 Jul; 473(1):35-40. PubMed ID: 12877935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
    Cowen MS; Djouma E; Lawrence AJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
    Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
    Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
    Rasmussen K; Martin H; Berger JE; Seager MA
    Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.